Skip to main contentAI and Advanced
/
SHALBY · NSEMarket ticker unavailable · configure an authorised index feed
SH
NSE · Equity shares · Healthcare Facilities-7.44 · -5.14%
Shalby SHALBY
NSE:INR 137.4
BSE:INR 164.25
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for SHALBY
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 144.84
Day rangeINR 136.35 — INR 149
52-week rangeINR 125.82 — INR 274.7
Volume3.64 L
Market cap1,780.49
P/E36.45
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,141.43
Net Income (INR Cr)37.39
Rev Growth (5 Year %)21.51
EPS Growth (5 Year %)-2.39
P/E Ratio36.45
Book Value85.44
EPS3.48
Price/BV1.61Computed
Research path: Interpret Shalby's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
SHALBYShalby1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,839.13 | 1,703.62 | 1,607.53 |
| Cash Equivalents | 0.03 | Not available | 0 |
| Other Liabilities Total | 14.85 | 14.6 | 14.58 |
| Accrued Expenses | 4.42 | 18 | 17.29 |
| Long Term Debt | 152.88 | 136.67 | 175.97 |
| Common Stock Total | 107.52 | 107.49 | 107.41 |
| Other Current Assets Total | 20.71 | 0.06 | 0.07 |
| Total Assets | 1,839.13 | 1,703.65 | 1,607.53 |
| Current Portof LT Debt/Capital Leases | 400.25 | 60 | 47.02 |
| Cash | 21.9 | 34.79 | 27.18 |
| Total Equity | 1,005.23 | 992.19 | 1,000.37 |
| Long Term Investments | 12.39 | 11.19 | 2.71 |
| Retained Earnings(Accumulated Deficit) | 897.71 | 447.67 | 454.01 |
| Total Common Shares Outstanding | 10.73 | 10.75 | 10.74 |
| Tangible Book Valueper Share Common Eq | 85.44 | 84.77 | 86.15 |
| Goodwill Net | 56.86 | 56.86 | 56.86 |
| Total Liabilities | 833.9 | 711.43 | 607.16 |
| Total Debt | 594.59 | 475.93 | 377.86 |
| Short Term Investments | 71.87 | 103.4 | 132.08 |
| Cashand Short Term Investments | 93.81 | 138.18 | 159.26 |
| Total Receivables Net | 228.42 | 183.98 | 151 |
| Deferred Income Tax | 48.55 | 63.14 | 35.02 |
| Accounts Receivable-Trade Net | 228.42 | 175.35 | 145.44 |
| Property/Plant/Equipment Total-Net | 976.19 | 896.37 | 906.54 |
| Minority Interest | 0.46 | 3.14 | 7.41 |
| Total Current Liabilities | 575.69 | 455.29 | 323.26 |
| Total Inventory | 376.38 | 331.63 | 238.8 |
| Accounts Payable | 128.49 | 118.42 | 129.57 |
| Other Currentliabilities Total | 42.54 | 18.21 | 25.42 |
| Total Long Term Debt | 194.34 | 175.27 | 226.89 |
| Intangibles Net | 31.65 | 24.13 | 18.2 |
| Other Long Term Assets Total | 36.51 | 12.83 | 18.15 |
| Note Receivable-Long Term | 6.2 | 44.31 | 52.83 |
| Total Current Assets | 719.33 | 657.96 | 552.25 |
| Capital Lease Obligations | 41.46 | 38.6 | 50.91 |
| Accumulated Depreciation Total | Not available | -359.76 | -308.5 |
| Other Equity Total | Not available | -1.72 | 0.93 |
| Prepaid Expenses | Not available | 4.12 | 3.13 |
| Additional Paid-In Capital | Not available | 438.76 | 438.03 |
| Property/Plant/Equipment Total-Gross | Not available | 1,248.08 | 1,204.39 |
| Notes Payable/Short Term Debt | Not available | 240.66 | 103.96 |
| Unrealized Gain(Loss) | Not available | -0.01 | -0.01 |
Fundamentals
Valuation and ratios
Growth
Debt 5Yr CAGR %61.5
Margins
Operating Margin 12m6.38
Operating Margin 5y Avg9.34
Net Profit Margin 12m3.04
Net Profit Margin 5y5.18
Yield
Dividend Yield %0
Valuation
Price to Sale Ratio1.56
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk40.97
Analyst consensus
ConsensusBuy
Consensus score2.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count1
Strong Buy count0
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,911.8 | 1.28 L | 64.93 | — |
| Max Healthcare Institute | INR 1,087.15 | 1.06 L | 71.47 | — |
| Fortis Healthcare | INR 955.6 | 72,073.21 | 67.89 | — |
| Aster DM Healthcare | INR 800.45 | 41,232.03 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,972.75 | 40,158.39 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 74.33%
- FII
- 4.47%
- MF
- 0.01%
- Other
- 21.19%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Stocks to buy or sell: Shilpa Medicare to Shalby — Sumeet Bagadia recommends five breakout stocksMarket news · 8 Jul 2024, 9:04 am
Stocks to buy or sell: Sumeet Bagadia has recommended buying these breakout stocks today — Shilpa Medicare, Marksans Pharma, Ahluwalia Contracts, Shalby, and BEPL
Shalby: This small-cap stock rallied 124% in just six months, up 218% in 3 yearsMarket news · 22 Nov 2023, 5:07 pm
Shares of Shalby, India’s leading multi-specialty hospital, have gained 124% in the last six months, moving from ₹ 139 to ₹ 311.15 per share. In today's trading session, the stock jumped 1.7% to hit a new record high of ₹ 323.60 apiece.
Q2 results preview: Hospital companies to be driven by higher occupancy, rising per bed revenuesMarket news · 19 Oct 2023, 1:46 pm
Q2 Result Preview: Better occupancy rates, improving average revenues per operating bed (APROB) are the key reasons which keep analysts positive on better performance by hospitals during Q2. Apollo, Fortis, Medanta (Global Health), Shalby, rainbow are amongst analysts top picks
Day trading guide for today: Six stocks to buy or sell on Friday — October 13Market news · 13 Oct 2023, 8:15 am
Day trading stocks: Market experts have recommended six stocks to buy today — HUL, DMart, Shalby, RBL Bank, Maruti Suzuki and Dr Lal Pathlabs
Shalby Hospitals Group to expand its footprint through Franchise ModelMarket news · 1 Sept 2021, 5:38 pm
SOCE is an opportunity for young and budding orthopedists from across regions as Shalby Hospitals opens doors to share its expertise with them.
Corporate actions
Events
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results & Final Dividend
Rusaka Markets Community
Discussion and sentiment for Shalby
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Shalby Limited is an India-based company, which operates multi-specialty hospital chains. The Company is engaged in the business of setting up and managing hospitals and medical diagnostic services. The Company’s Hospitals divisions include Multispecialty, Shalby Orthopedics Centre of Excellence (SOCE), Shalby Homecare, and Shalby Academy. Its Slaney Healthcare (Surgical & Pharma Products) divisions include Hosply (Hospital Supplies). Its Shalby MedTech divisions include Shalby Advanced Technologies Inc., USA (SAT), and Shalby Global Technologies PTE Ltd, Singapore (SGT). The Company offers a range of specialties, which include Bone and Joint, Cardiac Sciences, Cosmetic and Aesthetic, Dental Cosmetic and Implantology, Dermatology, Emergency Medicine, ENT Surgery, Gastro Sciences, General Medicine, General Surgery, Infertility and IVF, Intensive and Critical Care, Kidney Sciences, Liver Transplantation, Maxillofacial Surgery, Obstetrics and Gynaecology, Onco Sciences, and more.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- SHALBY
- BSE Code
- 540797
Questions
Stock FAQ
What is the symbol and ISIN of Shalby?
Shalby has the symbol SHALBY and ISIN - INE597J01018.
What is the current price of Shalby?
Shalby is currently trading at INR 137.40.
What are the year high and year low of Shalby?
Shalby has a year high of INR 274.70 and a year low of INR 125.82.
What is the market capitalization of Shalby?
Shalby has a market capitalization of INR 1,780.49 crore.
What is the P/E ratio of Shalby?
Shalby has a P/E ratio of 36.45.
What is the dividend yield of Shalby?
Shalby has a dividend yield of 0.00%.
How is the financial performance of Shalby based on revenue, net income, and EPS?
Shalby has revenue of INR 1,141.43 crore, net income of INR 37.39 crore, and EPS of INR 3.48.
What is the book value of Shalby?
Shalby has a book value of INR 85.44.
What is the debt-to-equity ratio of Shalby?
Shalby has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Shalby?
Shalby has a price-to-book ratio of 1.61 and a price-to-sales ratio of 1.56.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.